NDC 72266-237-01 - DOXYCYCLINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72266-237
- Requested NDC
- 72266-237-01
- Package NDCs from labels
- 72266-237-01, 72266-237-05
- Manufacturer
- FOSUN PHARMA USA INC | Gland Pharma Limited
- Effective date
- 2025-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOXYCYCLINE - FOSUN PHARMA USA INC | Gland Pharma Limited | FOSUN PHARMA USA INC | Gland Pharma Limited | 2025-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-237-01 | DOXYCYCLINE | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 6 | |
| 72266-237-05 | DOXYCYCLINE | 5 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 5 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-237-01 | EA - Each | 72266-237 | 4e56dc5a-99eb-4ea7-a739-b9786aac8631 | 1 | 2023-07-06 |
| 72266-237-05 | EA - Each | 72266-237 | 8a20933a-e1b8-489e-beba-2f3c2bfbc122 | 1 | 2023-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | 2023-04-10 | Warnings, Adverse reactions | 19XTS3T51U |
| Vitamin C Liquescence | CITRUS VULGARIS, CITRUS LIMONUM, MALPIGHIA SPP, PETROSELINUM SATIVUM, ROSA CANINA, AGARICUS MUSCARIUS, ASCORBICUM ACIDUM, CAPSICUM ANNUUM, MEDULLA OSSIS SUIS, SOLANUM TUBEROSUM | Nutritional Specialties, Inc. | 1864d967-071f-4c2f-a71a-f2b7da47a3d5 | 2023-03-28 | Warnings | PQ6CK8PD0R |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| CitriDrops | ASCORBICUM ACIDUM, CITRUS LIMONUN, PULSATILLA, SINAPIS NIGRA, LUFFA OPERCULATA, BERBERIS VULGARIS, EUPHORBIUM OFFICINARUM, GUAIACUM, HEPAR SULPHURIS CALCAREUM, MERCURIUS SULPHURATU RUBER | Micro Balance Health Products | f529aef5-ed57-7b26-e053-2995a90a5430 | 2023-02-20 | Warnings | PQ6CK8PD0R |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 6e587d8d-1a82-4dfa-acea-88704d408f2f | 2023-01-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 24c8472a-dd07-4f84-8bea-20a3f178d119 | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | ec4535a1-69f0-40a2-bcba-11afc75c721d | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Metab | ASCORBICUM ACIDUM, CYSTEINUM, MANGANESE GLUCONATE, ALPHA-KETOGLUTARICUM ACIDUM, FUMARICUM ACIDUM, GERMANIUM SESQUIOXIDE, IODIUM, MAGNESIUM METALLICUM, NATRUM OXALACETICUM, PULSATILLA (PRATENSIS), THYROIDINUM (SUIS), VANADIUM METALLICUM | Deseret Biologicals, Inc | fbf89a37-dca2-4498-8866-234b033c5d42 | 2023-01-12 | Warnings | PQ6CK8PD0R |
| Vitrexyl plus Iron | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ada43056-a3ce-e7de-e053-2a95a90aa046 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), PHLORIDZINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, BARYTA OXALICA, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, | Deseret Biologicals, Inc. | 5117f980-95b8-4fc8-9425-8f6f05639437 | 2022-12-29 | Warnings | PQ6CK8PD0R |
| Telomere - DNA | CA98, CAROTENOID, DNA, GLUTATHIONE, OMEGA 3, PITUITARUM, RNA, VITAMIN B COMPLEX, VITAMIN C, VITAMIN D3, VITAMIN E | ProBLEN | b093dfba-ed48-47a2-b4ce-f706221935a1 | 2022-11-30 | Warnings | PQ6CK8PD0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.